roflumilast
Showing 1 - 25 of 69
Peripheral Neuropathy Trial (Roflumilast, Placebo)
Not yet recruiting
- Peripheral Neuropathy
- Roflumilast
- Placebo
- (no location specified)
May 22, 2023
Long-term Observational Study of the Safety of Roflumilast
Completed
- COPD
- Roflumilast
-
Cambridge, Massachusetts
- +3 more
Oct 6, 2022
Psoriasis Trial in Copenhagen (Roflumilast)
Active, not recruiting
- Psoriasis
- Roflumilast
-
Copenhagen, DenmarkBispebjerg Hospital
Jul 7, 2022
Type 2 Diabetes (Adult Onset), Diabetic Neuropathies Trial in Tanta (Alpha lipoic acid, Roflumilast)
Recruiting
- Type 2 Diabetes (Adult Onset)
- Diabetic Neuropathies
- Alpha lipoic acid
- Roflumilast
-
Tanta, Egypt
- +1 more
Sep 20, 2022
Obesity, PreDiabetes Trial in Tanta (Roflumilast, )
Completed
- Obesity
- PreDiabetes
- Roflumilast
- placebo
-
Tanta, EgyptSara Mohammad Zayed
Apr 3, 2022
Fragile X Syndrome Trial in Cincinnati (Baclofen, Memantine, Roflumilast)
Recruiting
- Fragile X Syndrome
- Baclofen
- +3 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 28, 2022
Asthma Trial in Sacramento (Roflumilast, Placebo)
Recruiting
- Asthma
- Roflumilast
- Placebo
-
Sacramento, CaliforniaUC Davis
Jan 31, 2022
Respiratory Distress Syndrome, Adult Trial in Giza, Cairo (Roflumilast, Placebo)
Completed
- Respiratory Distress Syndrome, Adult
- Roflumilast
- Placebo
-
Giza, Doki, Egypt
- +1 more
Mar 22, 2022
Lymphoma, B-Cell Trial in San Antonio (Roflumilast)
Active, not recruiting
- Lymphoma, B-Cell
- Roflumilast
-
San Antonio, TexasMays Cancer Center, UT Health San Antonio
Mar 9, 2022
Synaptic Plasticity Trial in Calgary (Transcranial Magnetic Stimulation, Roflumilast, Placebo oral tablet)
Withdrawn
- Synaptic Plasticity
- Transcranial Magnetic Stimulation
- +2 more
-
Calgary, Alberta, CanadaUniversity of Calgary
Dec 23, 2021
COPD Severe, Chronic Bronchitis Trial in United States (Roflumilast, Azithromycin)
Recruiting
- Chronic Obstructive Pulmonary Disease Severe
- Chronic Bronchitis
- Roflumilast
- Azithromycin
-
Birmingham, Alabama
- +29 more
Mar 25, 2022
Diabetic Nephropathies Trial (Roflumilast, Placebo)
Unknown status
- Diabetic Nephropathies
- Roflumilast
- Placebo
- (no location specified)
Feb 15, 2021
COPD Trial in Stara Zagora (CHF6001 1600µg, CHF6001 3200µg, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- CHF6001 1600µg
- +3 more
-
Stara Zagora, BulgariaSite 100524 - Medical Centre New Rehabilitation Centre EOOD
Jul 27, 2021
COPD Trial in Philadelphia (Roflumilast, Placebo)
Completed
- COPD
- Roflumilast
- Placebo
-
Philadelphia, PennsylvaniaTemple University Hospital
Feb 20, 2020
Dementia Trial in Maastricht (roflumilast (EU: Daxas, USA: Daliresp), Placebo, roflumilast)
Completed
- Dementia
- roflumilast (EU: Daxas, USA: Daliresp)
- +2 more
-
Maastricht, Limburg, NetherlandsMaastricht University, Faculty of Psychology and Neuroscience
Dec 30, 2019
Bronchiectasis Adult Trial in São Paulo (Roflumilast, Placebo oral tablet)
Unknown status
- Bronchiectasis Adult
- Roflumilast
- Placebo oral tablet
-
São Paulo, SP, BrazilHeart Institute (InCor) - Hospital das Clínicas da Faculdade de
Jan 7, 2020
COPD, COPD Trial in Worldwide (Roflumilast, Placebo)
Completed
- COPD
- Chronic Obstructive Pulmonary Disease
- Roflumilast
- Placebo
-
Kobenhavn NV, Denmark
- +19 more
Nov 27, 2019
Exacerbation Copd, Bronchiectasis, Lung Function Decreased Trial in Songkhla (Roflumilast, Placebo)
Completed
- Exacerbation Copd
- +2 more
- Roflumilast
- Placebo
-
Songkhla, ThailandSongklanagarind hospital
Oct 9, 2019
Bronchiectasis Trial (Roflumilast)
Unknown status
- Bronchiectasis
- Roflumilast
- (no location specified)
Oct 1, 2019
COPD Trial in Guangzhou (Roflumilast, Placebo)
Terminated
- Chronic Obstructive Pulmonary Disease
- Roflumilast
- Placebo
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Guangzhou Medical University
May 20, 2019
COPD and Allied Conditions Trial in Vienna (Roflumilast, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease and Allied Conditions
- Roflumilast
- Placebo
-
Vienna, AustriaDeparment for Respiratory and Critical Care Medicine, Otto Wangn
Jan 14, 2019
Obesity Trial run by the NHLBI (Roflumilast)
Completed
- Obesity
- Roflumilast
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 28, 2018
COPD Trial in Farmington (Theophylline, Roflumilast)
Pulmonary Disease, Chronic Obstructive Trial in Edegem (HRCT scan, Placebo of Roflumilast, Roflumilast)
Terminated
- Pulmonary Disease, Chronic Obstructive
- HRCT scan
- +2 more
-
Edegem, Antwerp, BelgiumUniversity Hospital of Antwerp
Mar 19, 2018